Latest Peptide Research

Recent research on L-Carnitine: Effects of Acupuncture on Time-Dependent Muscle Endurance in Men with Post-Anterior Cruciate Ligament Injury: A Randomized Controlled Crossover Trial.

Recent research on Oxytocin: In the gravid human uterus, oxytocin induces smooth muscle cell contraction via transient receptor potential vanilloid 4 channel activation.

Recent research on Semaglutide: New weight loss pill outperforms oral semaglutide for diabetes patients, study reports.

Recent research on MOTS-c: MOTS-c Protects Against Acetaminophen-induced Liver Injury through the MAPK Signaling Pathway.

Recent research on GLP-1: Efficacy and safety of bofanglutide, a GLP-1 receptor agonist, in Chinese adults with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

Recent research on NAD+: Activation of IRF3 in cardiomyocytes impairs mitochondrial oxidative function through PGC-1α inhibition and drives heart failure.

Recent research on Tirzepatide: Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.

Recent research on L-Carnitine: Primary Carnitine Deficiency: A Stitch in Time Saves Nine.

Recent research on Semaglutide: Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer's disease via dual actions.

Recent research on Tirzepatide: Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting.

Recent research on Tirzepatide: Tirzepatide Combined With Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnoea Syndrome With Comorbid Obesity: Effects on Weight, Daytime Sleepiness, and Cognitive Performance.

Recent research on GLP-1: Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.